Please login to the form below

Not currently logged in
Email:
Password:

haemophilia

This page shows the latest haemophilia news and features for those working in and with pharma, biotech and healthcare.

UniQure skyrockets on haemophilia B gene therapy data

UniQure skyrockets on haemophilia B gene therapy data

UniQure skyrockets on haemophilia B gene therapy data. It’s a measure of the anticipation about gene therapy that data positive data in three haemophilia patients caused UniQure shares to close ... The phase 2b results for UniQure’s AMT-061 candidate

Latest news

  • AZ cuts $1.5bn-plus deal to pass US drug rights to Sobi AZ cuts $1.5bn-plus deal to pass US drug rights to Sobi

    The deal represents a major expansion for Sobi, which is currently focused on rare diseases and haemophilia in Europe (the latter through a licensing deal with Bioverativ), with limited penetration into

  • BioMarin eyes 2019 FDA filing for haemophilia A gene therapy BioMarin eyes 2019 FDA filing for haemophilia A gene therapy

    BioMarin eyes 2019 FDA filing for haemophilia A gene therapy. Valrox study revealed a 97% reduction in mean annual bleed rates. ... Rare disease specialist BioMarin is hoping to file for approval its haemophilia A gene therapy valoctocogene roxaparvovec

  • Ocrevus surge keeps Roche smiling in Q3 Ocrevus surge keeps Roche smiling in Q3

    Another bright spot for Roche was strong early uptake of new haemophilia A therapy Hemlibra (emicizumab), a blockbuster-in-waiting which added CHF 113m to the pot from its use in

  • Roche gets wider approval for haemophilia drug Hemlibra Roche gets wider approval for haemophilia drug Hemlibra

    Roche gets wider approval for haemophilia drug Hemlibra. Approved to treat bleeding episodes in patients without inhibitors. ... a saving over the current costs of treating haemophilia A, particularly among patients who go on to develop inhibitors.

  • Bayer roll-out of haemophilia drug Jivi gathers pace Bayer roll-out of haemophilia drug Jivi gathers pace

    Bayer roll-out of haemophilia drug Jivi gathers pace. Japan’s MHLW is next to approve the drug. ... Bayer has added another big market for its new haemophilia A product Jivi, adding approval in Japan to a green light in the US a few weeks ago.

More from news
Approximately 54 fully matching, plus 133 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 19 partially matching documents found.

Latest appointments

  • Sobi appoints Torbjorn Hallberg as general counsel Sobi appoints Torbjorn Hallberg as general counsel

    Also sitting on the new team are Sobi's head of specialty care Norbert Oppitz, h ead of medical and scientific affairs Armin Reininger, h ead of haemophilia Philip Wood and

  • Anne Prener to lead Freeline Therapeutics Anne Prener to lead Freeline Therapeutics

    Freeline comprises some of the world’s leading experts in gene therapy, haemophilia and other debilitating disorders and I look forward to working closely with them to demonstrate the potential of ... She has also worked at Novo Nordisk as senir vice

  • Clark Health Communications expands team Clark Health Communications expands team

    Campbell will support and assist the team across its women’s health, gastroenterology and haemophilia accounts.

  • Shire’s Dr Armin Reininger moves to Sobi Shire’s Dr Armin Reininger moves to Sobi

    global medical affairs for haemophilia. ... Armin will apply his deep experience as an industry leader and academic in haemophilia to our team, as well as his global experience in medical scientific affairs to our stakeholders.”.

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • The gene therapy revolution

    for instance to treat haemophilia, rare ophthalmic disorders and for Duchenne muscular dystrophy/DMD), genetic therapies are likely to represent a revolution in medicine over the coming years. ... However, in most areas where genetic treatments are being

  • Take a walk on the wild side!

    Say Comms Haemophilia Walk-a-Thon . What is this about a walk on the wild side? ... Where can I donate? You can donate to The Haemophilia Society via Say’ s fundraising page.

  • Living with haemophilia – the power of knowledge

    The issue of haemophilia and physical activity is therefore complex and can be confusing. ... Haemophilia 2013; 19 (4): 487– 498. 8. WFH guidelines for the management of hemophilia.

  • Attracting doctors to low-demand specialties: A role for industry?

    Haemophilia. One of the specialties in which Porterhouse has worked for many years is haemophilia, a disease that finds itself in a somewhat anomalous position. ... such as leukaemias, lymphomas and myelomas, while haemophilia warrants just one or two

  • Clark Health Communications unveils new positioning

    The agency continues to work on international programmes in multiple areas of women’ s health and in prostate cancer, haemophilia, sleep/breathing disorders, health informatics and medical diagnostic services and UK

More from PMHub
Approximately 3 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics